Treatment of Cancer with Immunomodulators: Corynebacterium parvum and Levamisole
- 1 May 1976
- journal article
- Published by Elsevier in Medical Clinics of North America
- Vol. 60 (3), 511-537
- https://doi.org/10.1016/s0025-7125(16)31895-8
Abstract
No abstract availableThis publication has 73 references indexed in Scilit:
- Mechanisms of macrophage activation by Corynebacterium parvumCellular Immunology, 1975
- The mechanism of inhibition byCorynebacterium parvum of the growth of lung nodules from intravenously-injected tumor cellsInternational Journal of Cancer, 1974
- Antitumour effects of Corynebacterium parvum in miceEuropean Journal of Cancer (1965), 1974
- The effect of preadministration ofCorynebacterium parvumon the protection afforded by heat-killed and acetone-killed vaccines against experimental mouse typhoidEpidemiology and Infection, 1974
- Restoration of host defense mechanisms in man by levamisoleLife Sciences, 1973
- Lympho-Reticular Stimulatory Properties of Corynebacterium Parvum and Related BacteriaJournal of Medical Microbiology, 1973
- A Taxonomic Study of Some Coryneform BacteriaJournal of General Microbiology, 1972
- Enhanced Resistance of Mice to Infection with Bacteria following Pre-treatment with Corynebacterium parvumNature New Biology, 1972
- An experimental model of active immunotherapy preceded by cytoreductive chemotherapyEuropean Journal of Cancer (1965), 1970
- MODIFICATIONS OF GRAFT-VERSUS-HOST REACTION INDUCED BY PRETREATMENT OF THE HOST WITH M. tuberculosis AND C. parvumTransplantation, 1965